By Counterforce Health Team in Orfadin (nitisinone) —

How to Get Orfadin (nitisinone) Covered by Cigna in Texas: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Orfadin (nitisinone) Covered by Cigna in Texas

Cigna requires prior authorization for Orfadin (nitisinone) with specific HT-1 documentation through Express Scripts specialty pharmacy. If denied, you have 180 days for internal appeals and can request Texas Independent Review Organization (IRO) external review within 4 months of final denial. For life-threatening cases or ongoing therapy denials, expedited IRO review (3 days) is available without completing internal appeals first.

Start today: Contact your metabolic specialist to gather elevated succinylacetone lab results, genetic testing, and dietitian's tyrosine/phenylalanine restriction plan for the prior authorization submission.

Table of Contents

  1. Understanding Cigna's Requirements
  2. Step-by-Step: Fastest Path to Approval
  3. Common Denial Reasons & How to Fix Them
  4. Appeals Playbook for Cigna in Texas
  5. Medical Necessity Letter Essentials
  6. Texas External Review Process
  7. Cost-Saving Options
  8. FAQ: Orfadin Coverage in Texas

Understanding Cigna's Requirements

Cigna classifies Orfadin (nitisinone) as a specialty medication requiring prior authorization and dispensing through Express Scripts or Accredo specialty pharmacy. The coverage criteria are strict but straightforward for confirmed hereditary tyrosinemia type 1 (HT-1) cases.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Cigna plans Cigna provider portal Cigna PA requirements
Specialty Pharmacy Must use Express Scripts/Accredo Denial letter or member services Express Scripts specialty
HT-1 Diagnosis ICD-10 code E70.29 required Medical records Cigna coverage policy
Lab Evidence Elevated succinylacetone levels Recent lab reports Medical records
Dietary Plan Registered dietitian documentation Nutrition consultation notes Treatment team
Specialist Prescriber Metabolic disease specialist Provider credentials Medical practice

Step-by-Step: Fastest Path to Approval

1. Confirm Your Diagnosis Documentation

Who does it: Your metabolic specialist
Documents needed: Recent succinylacetone lab results, genetic testing for FAH gene mutations
Timeline: Can be done same day if labs are current

2. Secure Dietitian Documentation

Who does it: Registered dietitian (metabolic specialty preferred)
Documents needed: Detailed tyrosine/phenylalanine restriction plan, compliance assessment
Timeline: 1-2 weeks for comprehensive plan

3. Complete Prior Authorization Form

Who does it: Prescriber's office
How to submit: Cigna provider portal or fax
Timeline: 5 business days for standard review, 24-72 hours expedited
Source: Cigna prior authorization process

4. Route Prescription to Specialty Pharmacy

Who does it: Prescriber sends to Express Scripts/Accredo
Required: Valid prior authorization number
Timeline: 2-3 business days for processing once approved

5. Monitor Approval Status

Who does it: Patient or caregiver
How: Call Express Scripts member services or check online portal
Follow-up: Within 3 business days if no response

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documents
Incomplete HT-1 diagnosis Submit elevated succinylacetone labs + genetic testing Recent lab reports, genetic test results
Missing dietary management Provide registered dietitian's comprehensive plan Detailed nutrition consultation notes
Non-specialist prescriber Transfer care or obtain specialist consultation Metabolic specialist involvement documentation
Retail pharmacy submission Resubmit through Express Scripts/Accredo only New prescription routed to specialty pharmacy
Insufficient medical records Submit complete treatment history and monitoring plan Comprehensive medical records, follow-up schedule
From Our Advocates: We've seen HT-1 cases initially denied for "incomplete documentation" get approved within days once families gathered the specific lab results (elevated succinylacetone) and dietitian plans that Cigna requires. The key is having all pieces together before the first submission—it saves weeks of back-and-forth.

Appeals Playbook for Cigna in Texas

Internal Appeals Process

Level 1 Appeal (Standard)

  • Deadline: 180 days from denial date
  • Timeline: 30 days for pre-service, 60 days for post-service
  • How to file: Cigna member portal, mail, or fax
  • Required: Original denial letter, medical records, prescriber letter

Expedited Internal Appeal

  • When available: Life-threatening conditions, ongoing therapy
  • Timeline: 72 hours for decision
  • How to request: Mark "URGENT" and provide clinical justification

Texas External Review (IRO)

After internal appeals are exhausted (or for urgent cases), Texas residents can request Independent Review Organization (IRO) review through the Texas Department of Insurance.

Key Timelines:

  • Standard IRO: 20 calendar days for decision
  • Expedited IRO: 3 days for life-threatening or ongoing therapy cases
  • Filing deadline: 4 months from final internal denial

Required Documents:

  • Final internal appeal denial letter
  • Signed medical information release form
  • IRO request form (TDI Form LHL712)
Note: For ongoing Orfadin therapy or life-threatening HT-1 complications, you can request expedited IRO review without completing internal appeals first.

Medical Necessity Letter Essentials

Your prescriber's letter of medical necessity should include these specific elements:

Core Components Checklist

  • ✅ Confirmed HT-1 diagnosis with ICD-10 code E70.29
  • ✅ Laboratory evidence: Specific succinylacetone levels with normal ranges
  • ✅ Genetic confirmation: FAH gene mutation details if available
  • ✅ FDA approval statement: "Orfadin is the only FDA-approved treatment for HT-1"
  • ✅ Risk without treatment: Progressive liver failure, hepatocellular carcinoma risk
  • ✅ Dosing rationale: Weight-based dosing calculation (0.5 mg/kg twice daily typical)
  • ✅ Dietary management: Registered dietitian involvement, tyrosine/phenylalanine restriction
  • ✅ Monitoring plan: Regular succinylacetone levels, liver function tests
  • ✅ Alternative considerations: Why diet alone is insufficient, generic options if relevant

Template Structure

RE: Medical Necessity for Orfadin (nitisinone)
Patient: [Name], DOB: [Date], Policy: [Number]

DIAGNOSIS: Hereditary Tyrosinemia Type 1 (ICD-10: E70.29)

DIAGNOSTIC EVIDENCE:
- Succinylacetone: [Value] μmol/L (normal <2)
- Genetic testing: FAH gene mutation [specify if available]
- Clinical presentation: [Brief summary]

MEDICAL NECESSITY:
Orfadin (nitisinone) is the only FDA-approved treatment for hereditary tyrosinemia type 1. Without treatment, patients develop progressive liver failure and hepatocellular carcinoma. Dietary restriction alone cannot prevent toxic metabolite accumulation.

TREATMENT PLAN:
- Orfadin [dose] mg twice daily based on current weight [kg]
- Strict tyrosine/phenylalanine-restricted diet (managed by registered dietitian)
- Regular monitoring: succinylacetone levels, liver function, growth parameters

SUPPORTING DOCUMENTATION ATTACHED:
- Recent laboratory results
- Genetic testing report
- Dietitian consultation notes
- Previous treatment records

Respectfully submitted,
[Prescriber name, credentials, contact information]

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with payer requirements—exactly what's needed for complex specialty drug cases like Orfadin.

Texas External Review Process

Texas provides robust external review rights for specialty drug denials through Independent Review Organizations (IROs). This process is particularly valuable for rare disease medications like Orfadin.

When IRO Review Applies

  • Denials based on medical necessity
  • Treatment deemed experimental/investigational
  • Step therapy or formulary restrictions
  • Special provision: Ongoing therapy or life-threatening conditions can bypass internal appeals

IRO Timeline Requirements

  • Life-threatening/ongoing therapy: 3 days maximum
  • Standard cases: 20 calendar days
  • Urgent preauthorization: 5 days for providers losing exemptions

Required Documentation

Submit to the IRO (assigned by TDI):

  • Complete medical records
  • All prior authorization requests and denials
  • Prescriber's clinical justification
  • Relevant medical literature supporting treatment
  • Signed authorization for medical record release

Contact for assistance: Texas Department of Insurance Consumer Help Line: 1-800-252-3439

Cost-Saving Options

Manufacturer Support

Sobi Cares Patient Support Program

  • Copay assistance for eligible patients
  • Prior authorization support services
  • Patient education materials
  • Contact: Verify current program details with prescriber or Sobi website

Foundation Assistance

  • Patient Advocate Foundation: Copay relief program for qualifying patients
  • HealthWell Foundation: May provide grants for HT-1 treatments
  • National Organization for Rare Disorders (NORD): Patient assistance programs

Alternative Options

  • Generic nitisinone: Available from multiple manufacturers, may reduce costs
  • Hospital charity care: For uninsured or underinsured patients
  • State programs: Texas may have additional rare disease support programs

FAQ: Orfadin Coverage in Texas

Q: How long does Cigna prior authorization take in Texas? A: Standard review is 5 business days. Expedited review for urgent cases is 24-72 hours. The timeline starts when Cigna receives complete documentation.

Q: What if Orfadin is non-formulary on my Cigna plan? A: You can request a formulary exception with medical necessity documentation. If denied, appeal through internal and external review processes.

Q: Can I request expedited appeal for ongoing Orfadin therapy? A: Yes. If you're currently taking Orfadin and face a denial, you can request expedited internal appeal and expedited IRO review in Texas without waiting for standard timelines.

Q: Does step therapy apply if I've failed treatments outside Texas? A: Previous treatment failures should be documented regardless of location. Provide complete medical records showing prior therapies and outcomes.

Q: What if my prescriber isn't a metabolic specialist? A: Cigna typically requires a metabolic disease specialist for HT-1 treatments. Your current prescriber can refer you or obtain specialist consultation to meet requirements.

Q: How do I know if my case qualifies for expedited IRO review? A: Cases involving life-threatening conditions or ongoing therapy (like continued Orfadin for HT-1) qualify. Your prescriber must document the urgency and potential harm from delays.

Q: What happens if the Texas IRO overturns Cigna's denial? A: The IRO decision is binding. Cigna must comply and cover the approved treatment. This typically happens within days of the IRO decision.

Q: Can I get help with the appeals process in Texas? A: Yes. Contact the Texas Department of Insurance (1-800-252-3439), Office of Public Insurance Counsel (1-877-611-6742), or organizations like Disability Rights Texas for assistance.

For families navigating complex specialty drug approvals, Counterforce Health provides comprehensive support by analyzing insurance policies, crafting targeted appeals, and ensuring all procedural requirements are met—turning the overwhelming appeals process into a systematic approach that maximizes approval chances.

Sources & Further Reading

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with qualified healthcare providers for medical decisions and follow your prescriber's recommendations for HT-1 treatment and monitoring.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.